Catalyst Wire Dossier Catalyst Wire Dossier

CRT device (cardiac resynchronization therapy)

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRT device (cardiac resynchronization therapy), covering 2017-02-23 to 2017-02-23. Get the full timeline:

Most recent: Clinical Trial Update: MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

See pricing